IIT Kgp commercialises COVID-19 diagnostic device COVIRAP
IIT Kgp commercialises COVID-19 diagnostic device COVIRAP
21 April 2021 | News Licensed for commercialisation to the Rapid Diagnostic Group of Companies, India and Bramerton Holdings LLC, USA
IIT Kharagpur (Kgp) has successfully commercialized its flagship healthcare product – COVIRAP – the novel diagnostic technology for infectious diseases including COVID-19 and beyond.
The product developed by lead researchers Professor Suman Chakraborty, Dr. Arindam Mondal and their research group has been licensed for commercialization to the Rapid Diagnostic Group of Companies, India and Bramerton Holdings LLC, USA.
Bramerton Holdings has signed a record deal for securing global rights for commercially disseminating the COVIRAP technology developed at IIT Kharagpur in various geographical locations outside the territory of the Indian subcontinent. Rapid Diagnostic has also initiated adapting the COVIRAP technology plat
IIT Kgp commercialises COVID-19 diagnostic device COVIRAP
IIT Kgp commercialises COVID-19 diagnostic device COVIRAP
21 April 2021 | News Licensed for commercialisation to the Rapid Diagnostic Group of Companies, India and Bramerton Holdings LLC, USA
IIT Kharagpur (Kgp) has successfully commercialized its flagship healthcare product – COVIRAP – the novel diagnostic technology for infectious diseases including COVID-19 and beyond.
The product developed by lead researchers Professor Suman Chakraborty, Dr. Arindam Mondal and their research group has been licensed for commercialization to the Rapid Diagnostic Group of Companies, India and Bramerton Holdings LLC, USA.
Bramerton Holdings has signed a record deal for securing global rights for commercially disseminating the COVIRAP technology developed at IIT Kharagpur in various geographical locations outside the territory of the Indian subcontinent. Rapid Diagnostic has also initiated adapting the COVIRAP technology plat
IIT-Kgp shows alterations in lung cell metabolism post COVID-19 infection
IIT-Kgp shows alterations in lung cell metabolism post COVID-19 infection
14 April 2021 | News The research would lead to a better understanding of metabolic reprogramming and aid the development of better therapeutics to deal with the viral pandemics
Image credit- shutterstock.com
Researchers at IIT Kharagpur (Kgp) have, for the first time, reported a method to find an alteration in metabolic reaction rates inside lung cells when they are affected by virus/pathogens. As the method finds and reports critical aspects of physiology, which are affected by SARS-CoV-2 infection, it will enable the discovery of therapeutic targets.